Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
![](https://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/6.png) |
Latest News |
|
|
Genomic Studies Utilize Scale As Clinical Utility Catches Up
Post analysing more than 8,000 tumours of 33 different malignancies, method has now been created to know role of internal factors in starting genetic changes.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/news/23598/Genomic-Studies-696x398.jpg) |
| |
| |
|
|
|
NIH Conducts Clinical Trial of The mRNA Nipah Virus Jab
Pandemic Preparedness Plan built a system for studying viruses with pandemic potential and gave prototype diseases like Nipah virus top priority in research.
|
|
|
| |
|
Brazil, India, SA Scientists Seek Speedier Antibiotic Nod
Study by One Health Trust found that taking antibiotic resistance in account could boost regulatory processes for quick medication nod in Brazil, India, and SA.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/press-releases/11097/novo-holdings-antibiotic-resistance-fight-696x393.jpg) |
|
|
| |
|
|
|
Serum Institute Wins USFDA Approval To Export Novavax Jab
It is anticipated that United States government will initiate distribution of the 3.2 million doses of Novavax that it has acquired by the end of this month.
|
|
|
![](https://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/7.png) |
Covid-19 Updates |
|
|
No Rush In Indian Generic Drug Firms To Offer COVID Products
Companies claim they want to wait and see before releasing new medications as COVID instances in India are moderate and responding to conventional treatment.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/2016/02/Deadly_Drug_Interactions-696x405.jpg) |
|
|
| |
|
|
|
As A Side Effect, EU Lists Allergies To Novavax COVID Shots
The Novavax COVID-19 vaccines potentially severe adverse effects, such as decreased skin sensitivity, have since been noted by the European Medicines Agency.
|
|
|
| |
|
COVID-19 Fourth Jab Reduces Death By 72% In The Elderly
Due to pre-existing medical issues, many of the elderly need assistance with daily tasks, are prone to severe infections and hence are included in the study.
|
|
![](https://www.worldpharmatoday.com/wp-content/uploads/news/21063/Vaccine_Booster-696x391.jpg) |
|
|